Septerna Stock
HealthTechLooking to sell Septerna stock or options?
Septerna, a biotechnology company, focuses on delivering innovative small molecule medicines that target G-protein-coupled receptors. By utilizing cutting-edge screening technologies and structure-based drug design, Septerna offers industrial-scale drug discovery solutions. This enables medical researchers to efficiently develop treatments for a diverse array of diseases, facilitating easier access to patient care.
RA Capital Management, Logos Capital, Woodline Partners, Mirae Asset Venture Investment, BVF Partners, Vertex Ventures HC, Mirae Asset Capital, Soleus Capital, Gershon Capital, Catalio Capital Management, Third Rock Ventures, Driehaus Capital, Deep Track Capital, Casdin Capital, Samsara BioCapital, Goldman Sachs Asset Management, Invus Financial Advisors, Vertex Ventures US.
Collective explained in 2 minutes
Learn how Collective's solutions enable you to manage your risk and maximize your wealth
Our available services for this company
Management Team
Board Members
Septerna’s stock FAQs
Septerna is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Septerna stock. Depending on Septerna’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Septerna stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Septerna stock in two ways. First, Septerna employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Septerna stock. Note that all transactions in Septerna shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Septerna stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Septerna stock. Typically, shares of private companies like Septerna are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jul 2023, Septerna is reported to have closed an equity financing in which the investors valued the company at $313M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Septerna shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Septerna is not currently publicly traded, it does not have a ticker symbol.
Septerna has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Septerna is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Septerna shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
